Thus, the aim of this study was to evaluate the influence of the use of the aglepristone (a competitive inhibitor of progesterone receptors) as a preoperative treatment on tumor tissue density as a parameter of mammary tumor differentiation, evaluated by shear wave elastography in the female domestic dog (Canis familiaris) benign tumor model. The gene discussed is PGR; the disease is breast cancer.